CANNAPHARMARX, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-12.9M | $27.8K |
| FY2022 | — | $17.3M | $2.3K |
| FY2023 | — | $-12.2M | $650 |
| FY2024 | — | $-19.8M | $2.2K |
| FY2025 | — | $-30.2M | $1.8K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-12.9M | $27.8K |
| FY2022 | — | $17.3M | $2.3K |
| FY2023 | — | $-12.2M | $650 |
| FY2024 | — | $-19.8M | $2.2K |
| FY2025 | — | $-30.2M | $1.8K |